A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Ankle Osteoarthritis

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

November 30, 2003

Study Completion Date

February 28, 2006

Conditions

Osteoarthritis

Interventions

DEVICE

Synvisc (hylan G-F 20)

Trial Locations (5)

Instituti Ortopedici Rizzoli, Bologna

Ospedale Santa Chiara, Clinica Ortopedica, Universita di Pisa, Pisa

Sportmedizinisches Institut Frankfurt am Main e.V. Orthopadie, Frankfurt

Johanna Etienne Krankenhaus, Neuss

Academisch Medisch Centrum, Amsterdam

All Listed Sponsors

lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00131768 - A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Ankle Osteoarthritis | Biotech Hunter | Biotech Hunter